Withdrawn Duke Trial Highlights Critical Need for Digital Health Onboarding Standards in Oncology Care

References

1. 1.Duke University. (2024). A Randomized Pilot Study Comparing the Feasibility of Using a Virtual Agent vs. an Off-site Human Agent to Onboard Oncology Patients to a Remote Monitoring Device. ClinicalTrials.gov. NCT06682013. https://clinicaltrials.gov/study/NCT06682013
2. 2.Brooke, J. (2013). SUS: A quick and dirty usability scale. In Usability Evaluation in Industry (pp. 189-194). CRC Press. https://doi.org/10.1201/9781498710411
3. 3.Sirintrapun, S. J., & Lopez, A. M. (2018). Telemedicine in cancer care. American Society of Clinical Oncology Educational Book, 38, 540-545. https://doi.org/10.1200/EDBK_200141
4. 4.Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197-198. https://doi.org/10.1001/jama.2017.7156
5. 5.Wildenbos, G. A., Peute, L., & Jaspers, M. (2018). Aging barriers influencing mobile health usability for older adults: A literature based framework. International Journal of Medical Informatics, 114, 66-77. https://doi.org/10.1016/j.ijmedinf.2017.12.012
6. 6.Noah, B., Keller, M. S., Mosadeghi, S., Stein, L., Johl, S., Delshad, S., ... & Spiegel, B. (2018). Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. NPJ Digital Medicine, 1(1), 1-12. https://doi.org/10.1038/s41746-017-0002-4